nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0925	0.463	CbGbCtD
Alfuzosin—CYP3A4—Progesterone—uterine cancer	0.0613	0.306	CbGbCtD
Alfuzosin—CYP3A4—Etoposide—uterine cancer	0.0274	0.137	CbGbCtD
Alfuzosin—CYP3A4—Doxorubicin—uterine cancer	0.0187	0.0935	CbGbCtD
Alfuzosin—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.00337	CcSEcCtD
Alfuzosin—Arthropathy—Epirubicin—uterine cancer	0.0027	0.00337	CcSEcCtD
Alfuzosin—Liver injury—Doxorubicin—uterine cancer	0.0027	0.00337	CcSEcCtD
Alfuzosin—Dyspepsia—Progesterone—uterine cancer	0.00269	0.00336	CcSEcCtD
Alfuzosin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00269	0.00336	CcSEcCtD
Alfuzosin—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.00334	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Progesterone—uterine cancer	0.00263	0.00329	CcSEcCtD
Alfuzosin—Fatigue—Progesterone—uterine cancer	0.00263	0.00329	CcSEcCtD
Alfuzosin—Constipation—Progesterone—uterine cancer	0.00261	0.00326	CcSEcCtD
Alfuzosin—Pain—Progesterone—uterine cancer	0.00261	0.00326	CcSEcCtD
Alfuzosin—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00323	CcSEcCtD
Alfuzosin—Cardiovascular disorder—Doxorubicin—uterine cancer	0.00258	0.00323	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00315	CcSEcCtD
Alfuzosin—Feeling abnormal—Progesterone—uterine cancer	0.00251	0.00314	CcSEcCtD
Alfuzosin—Arthropathy—Doxorubicin—uterine cancer	0.0025	0.00312	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Progesterone—uterine cancer	0.0025	0.00312	CcSEcCtD
Alfuzosin—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00246	0.00307	CcSEcCtD
Alfuzosin—Hepatocellular injury—Epirubicin—uterine cancer	0.00245	0.00307	CcSEcCtD
Alfuzosin—Ventricular tachycardia—Epirubicin—uterine cancer	0.00245	0.00307	CcSEcCtD
Alfuzosin—Ill-defined disorder—Dactinomycin—uterine cancer	0.00245	0.00306	CcSEcCtD
Alfuzosin—Infestation NOS—Etoposide—uterine cancer	0.00245	0.00306	CcSEcCtD
Alfuzosin—Infestation—Etoposide—uterine cancer	0.00245	0.00306	CcSEcCtD
Alfuzosin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00243	0.00304	CcSEcCtD
Alfuzosin—Urticaria—Progesterone—uterine cancer	0.00242	0.00303	CcSEcCtD
Alfuzosin—Abdominal pain—Progesterone—uterine cancer	0.00241	0.00302	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Etoposide—uterine cancer	0.0024	0.003	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00239	0.00298	CcSEcCtD
Alfuzosin—Jaundice—Etoposide—uterine cancer	0.00239	0.00298	CcSEcCtD
Alfuzosin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.00298	CcSEcCtD
Alfuzosin—Malaise—Dactinomycin—uterine cancer	0.00238	0.00298	CcSEcCtD
Alfuzosin—Influenza like illness—Epirubicin—uterine cancer	0.00238	0.00298	CcSEcCtD
Alfuzosin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00236	0.00296	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Etoposide—uterine cancer	0.00231	0.00289	CcSEcCtD
Alfuzosin—Neuropathy—Epirubicin—uterine cancer	0.0023	0.00288	CcSEcCtD
Alfuzosin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00285	CcSEcCtD
Alfuzosin—Hepatocellular injury—Doxorubicin—uterine cancer	0.00227	0.00284	CcSEcCtD
Alfuzosin—Ventricular tachycardia—Doxorubicin—uterine cancer	0.00227	0.00284	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00283	CcSEcCtD
Alfuzosin—Discomfort—Dactinomycin—uterine cancer	0.00222	0.00278	CcSEcCtD
Alfuzosin—Influenza like illness—Doxorubicin—uterine cancer	0.0022	0.00275	CcSEcCtD
Alfuzosin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.0022	0.00275	CcSEcCtD
Alfuzosin—Asthenia—Progesterone—uterine cancer	0.00219	0.00274	CcSEcCtD
Alfuzosin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00273	CcSEcCtD
Alfuzosin—Urinary tract disorder—Etoposide—uterine cancer	0.00217	0.00271	CcSEcCtD
Alfuzosin—Pruritus—Progesterone—uterine cancer	0.00216	0.0027	CcSEcCtD
Alfuzosin—Oedema—Dactinomycin—uterine cancer	0.00216	0.0027	CcSEcCtD
Alfuzosin—Urethral disorder—Etoposide—uterine cancer	0.00215	0.00269	CcSEcCtD
Alfuzosin—Infection—Dactinomycin—uterine cancer	0.00214	0.00268	CcSEcCtD
Alfuzosin—Neuropathy—Doxorubicin—uterine cancer	0.00213	0.00266	CcSEcCtD
Alfuzosin—Thrombocytopenia—Dactinomycin—uterine cancer	0.00211	0.00264	CcSEcCtD
Alfuzosin—Diarrhoea—Progesterone—uterine cancer	0.00209	0.00261	CcSEcCtD
Alfuzosin—Eye disorder—Etoposide—uterine cancer	0.00205	0.00257	CcSEcCtD
Alfuzosin—Cardiac disorder—Etoposide—uterine cancer	0.00204	0.00255	CcSEcCtD
Alfuzosin—Flushing—Etoposide—uterine cancer	0.00204	0.00255	CcSEcCtD
Alfuzosin—Dizziness—Progesterone—uterine cancer	0.00202	0.00252	CcSEcCtD
Alfuzosin—Angiopathy—Etoposide—uterine cancer	0.00199	0.00249	CcSEcCtD
Alfuzosin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00248	CcSEcCtD
Alfuzosin—Mediastinal disorder—Etoposide—uterine cancer	0.00198	0.00248	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00197	0.00246	CcSEcCtD
Alfuzosin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.00245	CcSEcCtD
Alfuzosin—Vomiting—Progesterone—uterine cancer	0.00194	0.00243	CcSEcCtD
Alfuzosin—Rash—Progesterone—uterine cancer	0.00192	0.0024	CcSEcCtD
Alfuzosin—Dermatitis—Progesterone—uterine cancer	0.00192	0.0024	CcSEcCtD
Alfuzosin—Headache—Progesterone—uterine cancer	0.00191	0.00239	CcSEcCtD
Alfuzosin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00236	CcSEcCtD
Alfuzosin—Fatigue—Dactinomycin—uterine cancer	0.00186	0.00232	CcSEcCtD
Alfuzosin—Back pain—Etoposide—uterine cancer	0.00185	0.00231	CcSEcCtD
Alfuzosin—Pain—Dactinomycin—uterine cancer	0.00184	0.00231	CcSEcCtD
Alfuzosin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00229	CcSEcCtD
Alfuzosin—Nausea—Progesterone—uterine cancer	0.00181	0.00227	CcSEcCtD
Alfuzosin—Osteoarthritis—Epirubicin—uterine cancer	0.00178	0.00223	CcSEcCtD
Alfuzosin—Feeling abnormal—Dactinomycin—uterine cancer	0.00178	0.00222	CcSEcCtD
Alfuzosin—Ill-defined disorder—Etoposide—uterine cancer	0.00177	0.00222	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00176	0.0022	CcSEcCtD
Alfuzosin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.0022	CcSEcCtD
Alfuzosin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00218	CcSEcCtD
Alfuzosin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00218	CcSEcCtD
Alfuzosin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00217	CcSEcCtD
Alfuzosin—Malaise—Etoposide—uterine cancer	0.00172	0.00216	CcSEcCtD
Alfuzosin—Vertigo—Etoposide—uterine cancer	0.00172	0.00215	CcSEcCtD
Alfuzosin—Abdominal pain—Dactinomycin—uterine cancer	0.00171	0.00213	CcSEcCtD
Alfuzosin—Loss of consciousness—Etoposide—uterine cancer	0.00168	0.0021	CcSEcCtD
Alfuzosin—Osteoarthritis—Doxorubicin—uterine cancer	0.00165	0.00206	CcSEcCtD
Alfuzosin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00205	CcSEcCtD
Alfuzosin—Chest pain—Etoposide—uterine cancer	0.00163	0.00204	CcSEcCtD
Alfuzosin—Abdominal pain upper—Epirubicin—uterine cancer	0.00163	0.00203	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Epirubicin—uterine cancer	0.00163	0.00203	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00162	0.00202	CcSEcCtD
Alfuzosin—Discomfort—Etoposide—uterine cancer	0.00161	0.00201	CcSEcCtD
Alfuzosin—Breast disorder—Epirubicin—uterine cancer	0.00161	0.00201	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.0016	0.002	CcSEcCtD
Alfuzosin—Infection—Etoposide—uterine cancer	0.00155	0.00194	CcSEcCtD
Alfuzosin—Asthenia—Dactinomycin—uterine cancer	0.00155	0.00193	CcSEcCtD
Alfuzosin—Thrombocytopenia—Etoposide—uterine cancer	0.00153	0.00191	CcSEcCtD
Alfuzosin—Tachycardia—Etoposide—uterine cancer	0.00152	0.0019	CcSEcCtD
Alfuzosin—Skin disorder—Etoposide—uterine cancer	0.00152	0.0019	CcSEcCtD
Alfuzosin—Hyperhidrosis—Etoposide—uterine cancer	0.00151	0.00189	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Doxorubicin—uterine cancer	0.0015	0.00188	CcSEcCtD
Alfuzosin—Abdominal pain upper—Doxorubicin—uterine cancer	0.0015	0.00188	CcSEcCtD
Alfuzosin—Angina pectoris—Epirubicin—uterine cancer	0.0015	0.00187	CcSEcCtD
Alfuzosin—Breast disorder—Doxorubicin—uterine cancer	0.00149	0.00186	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00148	0.00185	CcSEcCtD
Alfuzosin—Bronchitis—Epirubicin—uterine cancer	0.00148	0.00185	CcSEcCtD
Alfuzosin—Diarrhoea—Dactinomycin—uterine cancer	0.00148	0.00184	CcSEcCtD
Alfuzosin—Hypotension—Etoposide—uterine cancer	0.00146	0.00182	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00143	0.00179	CcSEcCtD
Alfuzosin—Somnolence—Etoposide—uterine cancer	0.00139	0.00173	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—uterine cancer	0.00139	0.00173	CcSEcCtD
Alfuzosin—Infestation NOS—Epirubicin—uterine cancer	0.00137	0.00171	CcSEcCtD
Alfuzosin—Drowsiness—Epirubicin—uterine cancer	0.00137	0.00171	CcSEcCtD
Alfuzosin—Infestation—Epirubicin—uterine cancer	0.00137	0.00171	CcSEcCtD
Alfuzosin—Vomiting—Dactinomycin—uterine cancer	0.00137	0.00171	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—uterine cancer	0.00137	0.00171	CcSEcCtD
Alfuzosin—Rash—Dactinomycin—uterine cancer	0.00136	0.0017	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Etoposide—uterine cancer	0.00135	0.00168	CcSEcCtD
Alfuzosin—Fatigue—Etoposide—uterine cancer	0.00135	0.00168	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Epirubicin—uterine cancer	0.00134	0.00168	CcSEcCtD
Alfuzosin—Jaundice—Epirubicin—uterine cancer	0.00134	0.00167	CcSEcCtD
Alfuzosin—Constipation—Etoposide—uterine cancer	0.00133	0.00167	CcSEcCtD
Alfuzosin—Pain—Etoposide—uterine cancer	0.00133	0.00167	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00132	0.00165	CcSEcCtD
Alfuzosin—Sweating—Epirubicin—uterine cancer	0.00132	0.00164	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Epirubicin—uterine cancer	0.0013	0.00162	CcSEcCtD
Alfuzosin—Sinusitis—Epirubicin—uterine cancer	0.00129	0.00161	CcSEcCtD
Alfuzosin—Feeling abnormal—Etoposide—uterine cancer	0.00129	0.00161	CcSEcCtD
Alfuzosin—Nausea—Dactinomycin—uterine cancer	0.00128	0.0016	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Etoposide—uterine cancer	0.00128	0.0016	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—uterine cancer	0.00127	0.00159	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—uterine cancer	0.00127	0.00159	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—uterine cancer	0.00127	0.00159	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.00124	0.00156	CcSEcCtD
Alfuzosin—Urticaria—Etoposide—uterine cancer	0.00124	0.00155	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—uterine cancer	0.00124	0.00155	CcSEcCtD
Alfuzosin—Rhinitis—Epirubicin—uterine cancer	0.00123	0.00154	CcSEcCtD
Alfuzosin—Abdominal pain—Etoposide—uterine cancer	0.00123	0.00154	CcSEcCtD
Alfuzosin—Pharyngitis—Epirubicin—uterine cancer	0.00122	0.00153	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—uterine cancer	0.00122	0.00152	CcSEcCtD
Alfuzosin—Urinary tract disorder—Epirubicin—uterine cancer	0.00122	0.00152	CcSEcCtD
Alfuzosin—Connective tissue disorder—Epirubicin—uterine cancer	0.00121	0.00151	CcSEcCtD
Alfuzosin—Urethral disorder—Epirubicin—uterine cancer	0.00121	0.00151	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—uterine cancer	0.0012	0.0015	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—uterine cancer	0.00119	0.00149	CcSEcCtD
Alfuzosin—Eye disorder—Epirubicin—uterine cancer	0.00115	0.00144	CcSEcCtD
Alfuzosin—Flushing—Epirubicin—uterine cancer	0.00114	0.00143	CcSEcCtD
Alfuzosin—Cardiac disorder—Epirubicin—uterine cancer	0.00114	0.00143	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—uterine cancer	0.00114	0.00143	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—uterine cancer	0.00113	0.00141	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—uterine cancer	0.00113	0.00141	CcSEcCtD
Alfuzosin—Asthenia—Etoposide—uterine cancer	0.00112	0.0014	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—uterine cancer	0.00112	0.0014	CcSEcCtD
Alfuzosin—Angiopathy—Epirubicin—uterine cancer	0.00112	0.0014	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—uterine cancer	0.00112	0.0014	CcSEcCtD
Alfuzosin—Mediastinal disorder—Epirubicin—uterine cancer	0.00111	0.00139	CcSEcCtD
Alfuzosin—Pruritus—Etoposide—uterine cancer	0.0011	0.00138	CcSEcCtD
Alfuzosin—Mental disorder—Epirubicin—uterine cancer	0.00108	0.00135	CcSEcCtD
Alfuzosin—Diarrhoea—Etoposide—uterine cancer	0.00107	0.00134	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—uterine cancer	0.00106	0.00133	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—uterine cancer	0.00106	0.00132	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—uterine cancer	0.00106	0.00132	CcSEcCtD
Alfuzosin—Back pain—Epirubicin—uterine cancer	0.00104	0.0013	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—uterine cancer	0.00103	0.00129	CcSEcCtD
Alfuzosin—Dizziness—Etoposide—uterine cancer	0.00103	0.00129	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—uterine cancer	0.00103	0.00128	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—uterine cancer	0.000998	0.00125	CcSEcCtD
Alfuzosin—Ill-defined disorder—Epirubicin—uterine cancer	0.000995	0.00124	CcSEcCtD
Alfuzosin—Vomiting—Etoposide—uterine cancer	0.000993	0.00124	CcSEcCtD
Alfuzosin—Rash—Etoposide—uterine cancer	0.000984	0.00123	CcSEcCtD
Alfuzosin—Dermatitis—Etoposide—uterine cancer	0.000983	0.00123	CcSEcCtD
Alfuzosin—Headache—Etoposide—uterine cancer	0.000978	0.00122	CcSEcCtD
Alfuzosin—Malaise—Epirubicin—uterine cancer	0.000967	0.00121	CcSEcCtD
Alfuzosin—Vertigo—Epirubicin—uterine cancer	0.000963	0.0012	CcSEcCtD
Alfuzosin—Syncope—Epirubicin—uterine cancer	0.000961	0.0012	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—uterine cancer	0.00096	0.0012	CcSEcCtD
Alfuzosin—Palpitations—Epirubicin—uterine cancer	0.000947	0.00118	CcSEcCtD
Alfuzosin—Loss of consciousness—Epirubicin—uterine cancer	0.000942	0.00118	CcSEcCtD
Alfuzosin—Nausea—Etoposide—uterine cancer	0.000927	0.00116	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—uterine cancer	0.00092	0.00115	CcSEcCtD
Alfuzosin—Chest pain—Epirubicin—uterine cancer	0.000913	0.00114	CcSEcCtD
Alfuzosin—Arthralgia—Epirubicin—uterine cancer	0.000913	0.00114	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000907	0.00113	CcSEcCtD
Alfuzosin—Discomfort—Epirubicin—uterine cancer	0.000902	0.00113	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—uterine cancer	0.000895	0.00112	CcSEcCtD
Alfuzosin—Dry mouth—Epirubicin—uterine cancer	0.000893	0.00112	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—uterine cancer	0.000891	0.00111	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—uterine cancer	0.00089	0.00111	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—uterine cancer	0.000877	0.0011	CcSEcCtD
Alfuzosin—Oedema—Epirubicin—uterine cancer	0.000875	0.00109	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—uterine cancer	0.000872	0.00109	CcSEcCtD
Alfuzosin—Infection—Epirubicin—uterine cancer	0.000869	0.00109	CcSEcCtD
Alfuzosin—Shock—Epirubicin—uterine cancer	0.000861	0.00108	CcSEcCtD
Alfuzosin—Nervous system disorder—Epirubicin—uterine cancer	0.000858	0.00107	CcSEcCtD
Alfuzosin—Thrombocytopenia—Epirubicin—uterine cancer	0.000857	0.00107	CcSEcCtD
Alfuzosin—Tachycardia—Epirubicin—uterine cancer	0.000854	0.00107	CcSEcCtD
Alfuzosin—Skin disorder—Epirubicin—uterine cancer	0.00085	0.00106	CcSEcCtD
Alfuzosin—Hyperhidrosis—Epirubicin—uterine cancer	0.000846	0.00106	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—uterine cancer	0.000845	0.00106	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—uterine cancer	0.000845	0.00106	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000839	0.00105	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—uterine cancer	0.000834	0.00104	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—uterine cancer	0.000826	0.00103	CcSEcCtD
Alfuzosin—Hypotension—Epirubicin—uterine cancer	0.000818	0.00102	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—uterine cancer	0.00081	0.00101	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—uterine cancer	0.000804	0.00101	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000797	0.000996	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—uterine cancer	0.000797	0.000996	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—uterine cancer	0.000794	0.000992	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000793	0.000991	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—uterine cancer	0.00079	0.000988	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—uterine cancer	0.000786	0.000983	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000783	0.000978	CcSEcCtD
Alfuzosin—Somnolence—Epirubicin—uterine cancer	0.000778	0.000972	CcSEcCtD
Alfuzosin—Dyspepsia—Epirubicin—uterine cancer	0.00077	0.000963	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—uterine cancer	0.000757	0.000946	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000755	0.000944	CcSEcCtD
Alfuzosin—Fatigue—Epirubicin—uterine cancer	0.000754	0.000943	CcSEcCtD
Alfuzosin—Pain—Epirubicin—uterine cancer	0.000748	0.000935	CcSEcCtD
Alfuzosin—Constipation—Epirubicin—uterine cancer	0.000748	0.000935	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000738	0.000922	CcSEcCtD
Alfuzosin—Feeling abnormal—Epirubicin—uterine cancer	0.000721	0.000901	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—uterine cancer	0.00072	0.0009	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000716	0.000894	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—uterine cancer	0.000713	0.000891	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000699	0.000874	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—uterine cancer	0.000698	0.000873	CcSEcCtD
Alfuzosin—Urticaria—Epirubicin—uterine cancer	0.000695	0.000869	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—uterine cancer	0.000692	0.000865	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—uterine cancer	0.000692	0.000865	CcSEcCtD
Alfuzosin—Abdominal pain—Epirubicin—uterine cancer	0.000692	0.000865	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—uterine cancer	0.000667	0.000834	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000662	0.000828	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—uterine cancer	0.000643	0.000804	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—uterine cancer	0.00064	0.0008	CcSEcCtD
Alfuzosin—Asthenia—Epirubicin—uterine cancer	0.000628	0.000785	CcSEcCtD
Alfuzosin—Pruritus—Epirubicin—uterine cancer	0.000619	0.000774	CcSEcCtD
Alfuzosin—Diarrhoea—Epirubicin—uterine cancer	0.000599	0.000748	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—uterine cancer	0.000581	0.000726	CcSEcCtD
Alfuzosin—Dizziness—Epirubicin—uterine cancer	0.000579	0.000723	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—uterine cancer	0.000573	0.000716	CcSEcCtD
Alfuzosin—Vomiting—Epirubicin—uterine cancer	0.000556	0.000695	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—uterine cancer	0.000554	0.000692	CcSEcCtD
Alfuzosin—Rash—Epirubicin—uterine cancer	0.000552	0.00069	CcSEcCtD
Alfuzosin—Dermatitis—Epirubicin—uterine cancer	0.000551	0.000689	CcSEcCtD
Alfuzosin—Headache—Epirubicin—uterine cancer	0.000548	0.000685	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—uterine cancer	0.000535	0.000669	CcSEcCtD
Alfuzosin—Nausea—Epirubicin—uterine cancer	0.00052	0.00065	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—uterine cancer	0.000515	0.000643	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—uterine cancer	0.00051	0.000638	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—uterine cancer	0.00051	0.000638	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—uterine cancer	0.000507	0.000634	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—uterine cancer	0.000481	0.000601	CcSEcCtD
